Amazon on Track for Record High Close — Data Talk
Amazon.com, Inc. (AMZN) is currently at $186.84, up $0.90 or 0.48%
--Would be new all-time high (Based on available data back to May 15, 1997)
--Would be first new record close since July 8, 2021, when it closed at $186.57
--Currently up six of the past seven days
--Currently up five consecutive days; up 3.8% over this period
--Longest winning streak since Jan. 29, 2024, when it rose for five straight trading days
--Best five day stretch since the five days ending Feb. 27, 2024, when it rose 3.87%
--Up 3.58% month-to-date
--Up 22.97% year-to-date
--Up 82.47% from 52 weeks ago (April 13, 2023), when it closed at $102.40
--Would be a new 52-week closing high
--Up 83.09% from its 52-week closing low of $102.05 on May 1, 2023
--Traded as high as $187.13
--Up 0.63% at today's intraday high
--Sixth most active stock in the S&P 500 today
--Fifth most active stock in the Nasdaq 100 today
--Contributed 5.91 points to the DJIA so far today
All data as of 11:20:31 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 11, 2024 11:37 ET (15:37 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track